COVID-19 Seroprevalence in Romania: Insights from a Nationwide Antibody Study
Background: Frequency indicators are used by epidemiologists to facilitate public health professionals in estimating the impact of diseases. As of April 2022, Romania had reported 2.8 million confirmed COVID-19 cases to the World Health Organization, equating to a prevalence rate of 13.94%. A more a...
Saved in:
| Main Authors: | Réka Bodea, Toader Septimiu Voidăzan, Lorand Iozsef Ferencz, Zoltán Ábrám |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Epidemiologia |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-3986/6/2/26 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the distribution and clustering of SARS-CoV-2 antibodies in dogs across the United States of America
by: Chi Chen, et al.
Published: (2025-07-01) -
A repeated cross-sectional analysis of SARS-CoV-2 seroprevalence in Manila, the Philippines after implementation of the national COVID-19 vaccination program
by: Greco Mark B. Malijan, et al.
Published: (2025-06-01) -
Evaluating Rubella Immunity in Women of Reproductive Age in Mysuru: A Cross-Sectional Serosurvey
by: Beebi Ameena1*, et al.
Published: (2024-12-01) -
A Nationwide Seroprevalence Study for Measles in Individuals of Fertile Age in Romania
by: Aurora Stanescu, et al.
Published: (2025-04-01) -
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations [version 2; peer review: 2 approved]
by: Henry Karanja, et al.
Published: (2025-07-01)